QuidelOrtho (QDEL) EPS (Basic) (2021 - 2026)

QuidelOrtho (QDEL) posted EPS (Basic) of $0.01 for Q1 2026, up 177.32% sequentially from -$0.01 in Q4 2025, and up 118.72% YoY from $0.0 in Q1 2025.

QuidelOrtho (QDEL) EPS (Basic) (2021 - 2026) Analysis & Trends

QuidelOrtho has reported EPS (Basic) for 6 years, with the latest figure at $0.01 in Q1 2026.

Quarterly EPS (Basic) rose 118.72% year-over-year to $0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.1 (up 67.65% YoY) and the FY2025 annual result came in at -$0.16, up 99.47% from the prior year.
EPS (Basic) advanced to $0.01 in Q1 2026 per QDEL's latest filing, from -$0.01 in the prior quarter.
Over five years, EPS (Basic) peaked at $11.45 in Q2 2022 and troughed at -$25.59 in Q1 2024.
A 5-year average of -$1.17 and a median of -$0.05 in 2025 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2024 and 2026: EPS (Basic) tumbled 3592.26% in 2024, then soared 118.72% in 2026.
Over 5 years, EPS (Basic) stood at $0.29 in 2022, then plunged by 2896.37% to -$8.03 in 2023, then surged by 99.3% to -$0.06 in 2024, then surged by 76.53% to -$0.01 in 2025, then soared by 177.32% to $0.01 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered $0.01, -$0.01, and -$0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.53
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	3.33
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.98
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.42
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.65
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.06
10	QuidelOrtho	1.03 Bn	908.95 Mn	-	0.02

Download Data